Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives. (2022)

First Author: Irving PM

Attributed to: Regulatory T cell therapy for IBD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1053/j.gastro.2022.02.014

PubMed Identifier: 35167865

Publication URI: http://europepmc.org/abstract/MED/35167865

Type: Journal Article/Review

Volume: 162

Parent Publication: Gastroenterology

Issue: 5

ISSN: 0016-5085